Cooper, Lyra
Rosen, Joseph G.
Zhang, Leanne
Pelaez, Danielle
Olatunde, Praise F.
Owczarzak, Jill
Park, Ju Nyeong
Glick, Jennifer L.
Article History
Received: 14 February 2023
Accepted: 10 May 2023
First Online: 9 June 2023
Declarations
:
: The study was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board.
: Not applicable.
: Dr. Park serves as a technical consultant at Harvard Medical School for a modeling project funded by the Food and Drug Administration (U01FD00745501). Dr. Glick and Johns Hopkins University receive grant funding from ViiV Healthcare to conduct PrEP-related research. The remaining authors have no competing interests to disclose.